BackChromocell Therapeutics Overview

Chromocell Therapeutics Goodwill

Chromocell Therapeutics's goodwill is $25M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$24.68M

Peer trimmed avg / median

Loading

Chromocell Therapeutics Goodwill History

Loading

Chromocell Therapeutics vs. peers: Goodwill Comparison

Loading

Chromocell Therapeutics Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Chromocell Therapeutics (CHRO) FAQ

As of the most recent data (June 2026), CHRO shows a goodwill of $25M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CHRO's goodwill is now $25M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Chromocell Therapeutics is outperforming or lagging.

Tracking CHRO's goodwill over time shows whether Chromocell Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $25M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Chromocell Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $25M) with ownership activity and broader fundamentals.